ASPIRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aspirin, and what generic alternatives are available?
Aspirin is a drug marketed by Amneal Pharms, Ani Pharms, Barr, Chartwell Molecular, Dr Reddys, Glenmark Pharms Sa, Micro Labs, Par Pharm Inc, Sandoz, Sun Pharm, and Zydus Pharms. and is included in eleven NDAs.
The generic ingredient in ASPIRIN is aspirin; dipyridamole. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aspirin; dipyridamole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aspirin
A generic version of ASPIRIN was approved as aspirin; dipyridamole by BARR on August 14th, 2009.
Summary for ASPIRIN
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 11 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ASPIRIN |
Drug Sales Revenues: | Drug sales revenues for ASPIRIN |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ASPIRIN |
DailyMed Link: | ASPIRIN at DailyMed |
Recent Clinical Trials for ASPIRIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Haaglanden Medical Centre | Phase 2 |
Amphia Hospital | Phase 2 |
Maastricht University Medical Center | Phase 2 |